1-methyl-4-phenyl-4-propionyloxypiperidine*HCl
更新时间：2024-01-10 18:54:09
1-methyl-4-phenyl-4-propionyloxypiperidine*HCl结构式
|
常用名 | 1-methyl-4-phenyl-4-propionyloxypiperidine*HCl | 英文名 | 1-methyl-4-phenyl-4-propionyloxypiperidine*HCl |
|---|---|---|---|---|
| CAS号 | 4968-48-3 | 分子量 | 283.79400 | |
| 密度 | N/A | 沸点 | N/A | |
| 分子式 | C15H22ClNO2 | 熔点 | N/A | |
| MSDS | N/A | 闪点 | 2 °C | |
| 符号 |
GHS02, GHS07 |
信号词 | Danger |
| 英文名 | 1-methyl-4-phenyl-4-propionyloxypiperidine*HCl |
|---|---|
| 英文别名 | 更多 |
| 分子式 | C15H22ClNO2 |
|---|---|
| 分子量 | 283.79400 |
| 精确质量 | 283.13400 |
| PSA | 29.54000 |
| LogP | 3.30060 |
| 符号 |
GHS02, GHS07 |
|---|---|
| 信号词 | Danger |
| 危害声明 | H225-H302 + H332-H319 |
| 警示性声明 | P210-P305 + P351 + P338 |
| 危险品运输编码 | UN 1648 3 / PGII |
| 闪点（华氏） | 35.6 °F |
| 闪点（摄氏） | 2 °C |
|
Glioma cell death induced by irradiation or alkylating agent chemotherapy is independent of the intrinsic ceramide pathway.
PLoS ONE 8(5) , e63527, (2013) Resistance to genotoxic therapy is a characteristic feature of glioma cells. Acid sphingomyelinase (ASM) hydrolyzes sphingomyelin to ceramide and glucosylceramide synthase (GCS) catalyzes ceramide met... |
|
|
Gas-liquid chromatographic-mass spectrometric determination of 1-methyl-4-phenyl-4-propionoxypiperidine using a stable isotope-labeled analogue as an internal standard.
J. Chromatogr. A. 408 , 356-9, (1987)
|
|
|
Involvement of gangliosides in glucosamine-induced proliferation decrease of retinal pericytes.
Glycobiology 15(6) , 585-91, (2005) The hexosamine pathway (HP) is a biochemical hypothesis recently proposed explaining cellular alterations occurring during diabetic microvascular complications. Diabetic retinopathy is a common microv... |
| 3-desmethyl prodine hydrochloride |
